Remi Gaston-Dreyfus - Jun 9, 2023 Form 4 Insider Report for Bionik Laboratories Corp. (BNKL)

Role
Director, 10%+ Owner
Signature
/s/ Remi Gaston-Dreyfus
Stock symbol
BNKL
Transactions as of
Jun 9, 2023
Transactions value $
$108,333
Form type
4
Date filed
6/21/2023, 10:57 AM
Previous filing
Jun 21, 2022
Next filing
Jun 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNKL Common Stock, par value $0.001 per share Purchase $108K +181K +11.05% $0.60 1.81M Jun 9, 2023 Shares held through GD Holdings and Lombard International Assurance SA F1, F2
holding BNKL Common Stock, par value $0.001 per share 61.3K Jun 9, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person acquired the shares of common stock in lieu of cash payment of $108,333 in accrued and unpaid fees relating to reporting person's services as a director of the Issuer.
F2 Includes 17,476 exchangeable shares of the Issuer's subsidiary.